Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Hematologic Neoplasms × apalutamide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Prostatic Neoplasms 65 Prostatic Neoplasms, Castration-Resistant 3 Prostatic Diseases 2 Neoplasm Metastasis 2 Genital Diseases, Male 2 Urogenital Neoplasms 1 Stage II Prostate Adenocarcinoma 1 Small Cell Lung Carcinoma 1 Salivary Gland Neoplasms 1 Prostate Cancer With ≤10 Bone Metastases 1 Prostate Cancer Metastatic Disease 1 Prostate Cancer Metastatic 1 Prostate Adenocarcinoma 1 Patient Preference 1 Non-Muscle Invasive Bladder Urothelial Carcinoma 1 Newly Diagnosed Oligometastatic Prostate Cancer 1 Neoplasms by Site 1 Neoplasms 1 Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) 1 Metastatic Castration-sensitive Prostate Cancer 1 Metastatic Castration-resistant Prostate Neoplasms 1 Metastatic Castration-resistant Prostate Cancer (mCRPC) 1 Metastatic Castration-Resistant Prostate Cancer 1 Metastatic Castrate-sensitive Prostate Cancer 1 Low Risk Prostate Cancer 1 High-Risk and Oligometastatic Prostate Cancer 1 High Risk Prostate Cancer 1 Hematologic Neoplasms 1 Genital Neoplasms, Male 1 Castration Levels of Testosterone 1

Interventions

Cyclophosphamide 75 fludarabine 65 fludarabine phosphate 40 Tacrolimus 39 Whole-Body Irradiation 37 Mycophenolic Acid 34 Busulfan 30 Melphalan 27 Antilymphocyte Serum 21 thymoglobulin 20 Methotrexate 20 Sirolimus 19 Thiotepa 18 Standard of Care 18 Rituximab 17 Azacitidine 17 venetoclax 16 Stem Cell Transplantation 16 Granulocyte Colony-Stimulating Factor 16 Practice Guidelines as Topic 15 Cytarabine 14 Filgrastim 13 Mesna 12 Bortezomib 12 Nivolumab 10 Peripheral Blood Stem Cell Transplantation 9 Dexamethasone 9 Blood Specimen Collection 9 trametinib 8 Specimen Handling 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05159245 2024-07-15

FINPROVE

Helsinki University Central Hospital

Phase 2 Recruiting

Other hematologic neoplasm

Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡